Alexza Pharmaceuticals grants Grupo Ferrer exclusive commercialization rights to Adasuve (AZ-004) in Europe, Latin America and the Commonwealth of Independent States (CIS)

Alexza Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$85.8m on 10/07/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Grupo Ferrer Internacional S.A.

Spain / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced